Showing results (1-10 of 700) with videos related to
Sort By:
Pageof 70
The Journal of Molecular Diagnostics : JMD|October 4, 2008
KRAS mutations: an old oncogene becomes a new predictive biomarkerGregory J Riely, Marc LadanyiSeminars in Diagnostic Pathology|November 19, 2008
KRAS mutational testing in the selection of patients for EGFR-targeted therapiesJoaquin Garcia, Gregory J Riely, Khedoudja Nafa, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 27, 2013
KRAS mutations are associated with solid growth pattern and tumor-infiltrating leukocytes in lung adenocarcinomaNatasha Rekhtman, Daphne C Ang, Gregory J Riely, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2008
Acquired resistance to epidermal growth factor receptor kinase inhibitors associated with a novel T854A mutation in a patient with EGFR-mutant lung adenocarcinomaJames Bean, Gregory J Riely, Marissa Balak, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 10, 2014
Massively parallel sequencing identifies recurrent mutations in TP53 in thymic carcinoma associated with poor prognosisAndre L Moreira, Helen H Won, Robert McMillan, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 18, 2012
Lungs don't forget: Comparison of the KRAS and EGFR mutation profile and survival of collegiate smokers and never smokers with advanced lung cancersAnna M Varghese, Camelia S Sima, Jamie E Chaft, et al.Lung Cancer (Amsterdam, Netherlands)|June 3, 2008
The use of first-generation tyrosine kinase inhibitors in patients with NSCLC and somatic EGFR mutationsGregory J RielyClinical Advances in Hematology & Oncology : H&O|April 9, 2016
Should EGFR tyrosine kinase inhibitors be used in non-small cell lung cancer in the absence of EGFR mutations? No, EGFR TKIs should be reserved for patients with EGFR mutationsGregory J RielyJournal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 27, 2008
Second-generation epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancerGregory J RielyJournal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 17, 2014
Germline EGFR T790M mutation found in multiple members of a familial cohortHelena A Yu, Maria E Arcila, Megan Harlan Fleischut, et al.Pageof 70